New Researches In Treatment Of Rheumatoid Arthritis – Part 1 of 3
New Researches In Treatment Of Rheumatoid Arthritis. About half of rheumatoid arthritis patients stopped taking their medications within two years after they started them, a original bone up finds June 2013. Rheumatoid arthritis affects about one in 100 people worldwide and can cause progressive joint destruction, deformity, pain and stiffness. The disease can reduce actual function, quality of life and life expectancy. The main reason about one-third of patients discontinued their medications was because the drugs lost their effectiveness, the study authors found. Other reasons included refuge concerns (20 percent), doctor preference (nearly 28 percent), patient preference (about 18 percent) and access to treatment (9 percent), according to the sanctum results, which were presented Thursday at the annual meeting of the European League Against Rheumatism (EULAR), in Madrid, Spain.
Rheumatoid arthritis “is a progressive disease, which, if left untreated, can significantly and always reduce joint function, patient mobility and quality of life,” study lead author Dr Vibeke Strand, a clinical professor at Stanford University School of Medicine, said in an EULAR dirt release. “Studies have shown that patients sustain maximum benefit from rheumatoid arthritis treatment in the first two years – yet our data highlight significant discontinuation rates during this interval period”.